-
-
-
-
-
-
News
-
-
Contact UsThe company focuses on the research, development, production, and sales of chemical raw materials and their formulations. All products have passed national GMP certification, and core products have successively passed official pharmaceutical regulatory certifications from multiple countries, including the EU EDQM, US FDA, Japanese PMDA, and South Korean MFDS. Following its successful listing on the Shenzhen Stock Exchange's ChiNext board on April 4, 2023, Keyuan Pharmaceutical has entered a phase of rapid development driven by both digital intelligence and capital, with its business spanning dozens of countries and regions worldwide.
Connecting the World, Shaping the Future | Keyuan Pharma & Linuo Pharma Make a Stunning Debut at API China 2024 (Shanghai)!
Publish Time:
2024-05-15
On May 15, 2024, API China, the 88th National Pharmaceutical Fair, and the 2024 China International Health & Nutrition Expo grandly opened at the Shanghai National Exhibition and Convention Center. As a leading enterprise in China's niche segment of chemical APIs, Keyuan Pharmaceutical (stock code: 301281.SZ), together with its wholly-owned subsidiary Linuo Pharmaceutical, was invited to participate in this prestigious event.
On May 15, 2024, API China, the 88th National Pharmaceutical Fair, and the 2024 China International Health & Nutrition Expo grandly opened at the Shanghai National Exhibition and Convention Center. As a leading enterprise in China's niche segment of chemical APIs, Keyuan Pharmaceutical (stock code: 301281.SZ), together with its wholly-owned subsidiary Linuo Pharmaceutical, was invited to participate in this prestigious event.
API China is a renowned pharmaceutical raw material, intermediate, and packaging equipment trade fair in China and throughout Asia, attracting pharmaceutical companies from around the globe each year.
This year's joint "Three Exhibitions" brought together thousands of pharmaceutical companies in Shanghai, seamlessly connecting the entire pharmaceutical and healthcare industry chain—enabling effective interaction, smooth integration, and comprehensive coverage among companies across the value chain.
 |
 |
 |
 |
 |
 |
KeYuan Pharmaceutical has been deeply rooted in the chemical API field for many years, with products spanning key therapeutic areas such as antidiabetic, anesthetic, cardiovascular, and psychiatric treatments. Following its successful IPO on the ChiNext Board of the Shenzhen Stock Exchange, KeYuan Pharmaceutical has embarked on a phase of rapid growth driven by both digital innovation and capital, now expanding its business to dozens of countries and regions worldwide.
As a wholly-owned subsidiary of Keyuan Pharmaceutical, Linuo Pharmaceutical fully leverages its unique advantages in integrated raw material and formulation production, as well as integrated excipient and formulation development, and has seen rapid growth momentum in the formulation sector in recent years.
Leveraging the inherent advantages of a vertically integrated upstream-to-downstream industrial chain—combining raw materials with advanced formulations—Keyuan Pharmaceutical and Linuo Pharmaceutical continue to strengthen their presence in the pharmaceutical market. By consistently pursuing strategies that prioritize technology R&D to maintain leadership, uphold quality systems to build trust, and focus on customer satisfaction to drive growth, the companies are steadily enhancing their innovation capabilities and market competitiveness, enabling them to achieve both high-quality development and accelerated growth!
At the exhibition venue, the booths of Keyuan Pharmaceutical and Linuo Pharmaceutical were located at 1.2S25. The overall tech-blue color scheme highlighted the unique charm of digital and intelligent pharmaceuticals, drawing numerous existing and new customers to engage in lively discussions and exchanges. The area was bustling with activity and brimming with energy.
Jiang Hongsheng, Chairman of Keyuan Pharmaceutical and Linuo Pharmaceutical; Du Hongshan, President of Linuo Pharmaceutical; and Cui Chunlai, Vice President of Marketing at Keyuan Pharmaceutical, led their teams to showcase the company’s innovative achievements to partners, discuss industry development trends, and jointly advance the growth of collaborative relationships.
Latest News
Address: No. 26, Keyuan Street, Shanghe County, Jinan City, Shandong Province
Free Service Hotline